Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma

JAMA Oncol. 2020 Dec 1;6(12):1972-1974. doi: 10.1001/jamaoncol.2020.4937.

Abstract

This cohort study evaluates the national practice patterns of MGMT gene testing and identified potential factors associated with access to testing.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain Neoplasms / diagnosis*
  • Brain Neoplasms / genetics
  • Clinical Decision-Making
  • DNA Methylation*
  • DNA Modification Methylases / genetics*
  • DNA Repair Enzymes / genetics*
  • Epigenesis, Genetic
  • Female
  • Glioblastoma / diagnosis*
  • Glioblastoma / genetics
  • Health Equity
  • Humans
  • Male
  • Middle Aged
  • Molecular Diagnostic Techniques
  • Socioeconomic Factors
  • Tumor Suppressor Proteins / genetics*

Substances

  • Tumor Suppressor Proteins
  • DNA Modification Methylases
  • MGMT protein, human
  • DNA Repair Enzymes